参考文献 References
[1] 苏梦婵,郑莹.2022《NCCN遗传性/家族性卵巢癌风险评估与临床管理指南(第1版)》解读[J].实用妇产科杂志,2022,38(07):508-512.
[2] Pulido H, Ammons M, Bakri R, et al. Borderline Brenner Tumor of the Ovary: Case Report and Review of the Literature[J]. Journal of Medical Case Reports, 2022, 1(1): 1-4.
[3] Yu J, Jiang P, Zhao K, et al. Role of DACH1 on proliferation, invasion, and apoptosis in human lung adenocarcinoma cells[J]. Current Molecular Medicine, 2021, 21(9): 806-811.
[4] Wang R R, Liu W S, Zhou L, et al. Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics[J]. Journal of Biomolecular Structure and Dynamics, 2020, 38(5): 1525-1538.
[5] Jiao J, Wen L, Wang Z, et al. Highly Sensitive Sensor Based on Pt@ MnO2/rGO Nanosheets as a Platform for Real-time Monitoring Cellular ROS and its Application in Diverse Cancers[J]. Journal of The Electrochemical Society, 2020, 167(6): 67524-67527.
[6] Yue X, Yue Z, Wang Y, et al. Value of the Copenhagen index in the diagnosis of malignant adnexal tumors: A meta‐analysis[J]. International Journal of Gynecology & Obstetrics, 2023, 160(2): 506-515.
[7] Zhang S, Guo B, He S, et al. Characterization of the complete chloroplast genome of Rumex dentatus L.(Polygonaceae)[J]. Mitochondrial DNA Part B, 2022, 7(3): 546-547.
[8] Li X, Cao L, Zheng J. Inhibition of invasion and migration of hepatoblastoma cells by miR-885-5p via targeting of glypican-3[J]. Materials Express, 2020, 10(12): 2019-2024.
[9] Cheng H, Yang Q, Wang R, et al. Emerging advances of detection strategies for tumor-derived exosomes[J]. International Journal of Molecular Sciences, 2022, 23(2): 868-874.
[10] Roman G. Anticancer activity of Mannich bases: a review of recent literature[J]. ChemMedChem, 2022, 17(16): 202200258-202200263.
[11] Lingzhi Z, Meirong L, Xiaobing F. Biological approaches for hypertrophic scars[J]. International wound journal, 2020, 17(2): 405-418.
[12] Aboushanab S A, Khedr S M, Gette I F, et al. Isoflavones derived from plant raw materials: bioavailability, anti-cancer, anti-aging potentials, and microbiome modulation[J]. Critical Reviews in Food Science and Nutrition, 2022, 63(2): 261-287.
[13] 邓黎,梁志清.腹腔镜在卵巢癌手术评估与治疗中的临床应用现状[J].实用妇产科杂志,2022,38(03):173-176.
[14] Chermuła B, Kranc W, Celichowski P, et al. Cellular Processes in Human Ovarian Follicles Are Regulated by Expression Profile of New Gene Markers—Clinical Approach[J]. Journal of Clinical Medicine, 2021, 11(1): 73-77.
[15] Wang B, Jia Y, Liu L. The efficacy and safety of platinum-based chemotherapy for ovarian cancer in pregnancy: A protocol for systematic review and meta-analysis[J]. Medicine, 2022, 101(47): 31954-31955.
[16] Pulido H, Ammons M, Bakri R, et al. Borderline Brenner Tumor of the Ovary: Case Report and Review of the Literature[J]. Journal of Medical Case Reports, 2022, 1(1): 1-4.
[17] Murahari M, Singh V, Chaubey P, et al. A critical review on anticancer mechanisms of natural flavonoid puerarin[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2020, 20(6): 678-686.
[18] Merlier M, Kerbage Y, Pierache A, et al. Impact on prognosis of the surgical route, laparoscopy or laparotomy, for the surgical staging of early stage ovarian cancer—a study from the FRANCOGYN Group[J]. Journal of Clinical Medicine, 2020, 9(11): 3528-3537.
[19] Liang X, Ji M, Liao Z, et al. Chemosensitizing effect and mechanism of imperatorin on the anti-tumor activity of doxorubicin in tumor cells and transplantation tumor model[J]. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology, 2022, 26(3): 145-155.
[20] Lim C K, Kim D Y, Cho A, et al. Role of minimally invasive surgery in early ovarian cancer[J]. Gland Surgery, 2021, 10(3): 1252-1255.
[21] Jochum F, Vermel M, Faller E, et al. Three and five-year mortality in ovarian cancer after minimally invasive compared to open surgery: a systematic review and meta-analysis[J]. Journal of Clinical Medicine, 2020, 9(8): 2507-2511.
[22] Odajima S, Ueda K, Hosoya S, et al. Clinical availability of tumour biopsy using diagnostic laparoscopy for advanced ovarian cancer[J]. in vivo, 2021, 35(6): 3325-3331.
[23] Tomasch G, Lemmerer M, Oswald S, et al. Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy[J]. Journal of British Surgery, 2020, 107(5): 519-524.
[24] Lecointre L, Pellerin M, Venkatasamy A, et al. Complete laparoscopic interval debulking surgery for advanced ovarian cancer achieves similar survival outcomes to open approach: a propensity-matched study[J]. Journal of Investigative Surgery, 2022, 35(6): 1394-1401.
[25] Kurnit K C, Fleming G F, Lengyel E. Updates and new options in advanced epithelial ovarian cancer treatment[J]. Obstetrics and gynecology, 2021, 137(1): 108-112.